查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197820

眼科诊断市场——增长、趋势和预测 (2023-2028)

Ophthalmology Diagnostics Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 100 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，眼科诊断市场预计将以约 5.8% 的复合年增长率增长。

随着诊所和初级保健中心的关闭，COVID-19 在早期阶段对眼科诊断市场产生了重大影响。 结果，到眼科就诊的患者数量急剧减少。 然而，一旦限制放鬆，该行业就会强劲反弹。 近两年来，眼科诊断设备销量增加、新产品上市、眼科评估诊断需求增加，带动了市场復苏。

推动市场增长的主要因素是青光眼、眼睛疲劳、白内障、色盲和糖尿病性视网膜病变等各种眼病在全球的流行。 这些疾病需要早期诊断才能有效治疗。 此外，快速增长的老年人口正在增加世界可避免失明的负担并提高医疗保健意识。 这将导致定期进行健康检查并提振市场。 例如，根据 BrightFocus Foundation 的 2021 年更新，超过 300 万美国人患有青光眼。 其中，40 岁以上的 270 万人患有最常见的开角型青光眼。 2022 NEI 更新估计，在 2010 年至 2050 年间，白内障患者人数将从 2440 万增加一倍至 5000 万。 因此，眼部相关疾病负担的增加以及对其筛查和诊断的增加预计将对市场增长产生重大影响。 此外，根据2022年4月发表的论文“Frontiers”，在中老年人糖尿病视网膜病变（DR）的检测中，定期筛查（每年筛查或前5年每年筛查2次）优于不定期筛查，发现超标

综上所述，相信未来眼科诊断市场将不断扩大。 然而，眼科诊断设备的高成本和熟练专业人员的短缺阻碍了市场的增长。

眼科诊断市场趋势

在眼科诊断市场，手术评估板块有望占据较大市场份额

由于白内障和糖尿病视网膜病变等疾病的高患病率，预计手术评估部分在预测期内将占据很大份额。 随着白内障手术的增加，全世界对手术评估的需求不断增长。 例如，CDC 报告称，17.2% 的 40 岁以上美国人至少有一隻眼睛患有白内障（约 2050 万人）。 到 2028 年，预计将有超过 3000 万人患有白内障。

与眼科手术领域相关的产品发布、併购和研究将推动市场增长。 例如，2021 年 7 月，佳能推出了广域扫描光学相干断层扫描 (OCT)“Xephilio OCT-S1”，单次扫描可捕获高达 23 x 20 毫米的高分辨率图像。 该产品在 APACRS-SNEC 联合活动中展示给了眼保健医生。 佳能的深度扫描扫描光源技术可实现约 80 度的广角操作。 此外，2022 年 3 月，专注于治疗青光眼的全球医疗器械公司 New World Medical 更新了 STREAMLINETM 手术系统的发布计划。 STREAMLINE 是一种一次性设备，采用直观的点击脉衝技术，是一线的无植入系统，旨在在小梁网中进行精确的房角切开术。 此外，眼科粘性手术装置 (OVD) 可以一步以小增量输送到施累姆氏管中。 此外，2021 年 7 月，强生 (J&J) Vision 将在全球推出超声乳化 (FACO) 系统，该系统旨在提高外科医生在白内障手术中的效率和舒适度。底部。 超声乳化是最常见的白内障手术类型，当白内障导致晶状体变浑浊时，医生可以将其乳化并取出眼内晶状体。

因此，考虑到上述因素，手术评估部分很可能在预测期内出现增长。

北美预计在预测期内见证眼科诊断市场的增长

由于白内障和糖尿病性视网膜病变等眼病的患病率急剧上升，以及老年人口的显着增加，预计在预测期内，北美的整体眼科诊断市场将实现健康增长在美国... 例如，在 2021 年青光眼宣传月中，COS-SCO 表示每年有超过 800,000 名加拿大人患有青光眼。 在宣传月期间，加拿大人口老龄化等因素导致疾病负担增加。 未来几年，青光眼很可能在加拿大流行，预计这将推动市场增长。

此外，政府在眼科领域的举措不断增加也推动了市场增长。 例如，每年 3 月 6 日至 12 日举办世界青光眼周，以提高人们对青光眼的认识。 2022年，本次活动的宗旨是“世界光明，保护视力”。 目的是引起人们对青光眼定期筛查和早期诊断的关注。 此外，市场参与者已采取各种策略，如产品发布、开发、收购、合作、合併和扩张，以增加其市场份额。 例如，2021年1月，爱尔康在美国商业化推出了非衍射焦深人工晶状体（IOL）“AcrySof”。 此外，2022 年 3 月，掌上眼底相机供应商 Epipole 在纽约 Vision Expo East 2022 上推出了一款新的眼底相机 epiCam。 epiCam 是一款高功率、超便携、无线视网膜相机，可通过 epipole 的新 VDO（视频直接检眼镜）平台捕捉高分辨率实时视频和伴随的活体视网膜静止图像。

综上所述，预计北美地区在预测期内将实现增长。

光学诊断市场竞争对手分析

眼科诊断市场竞争适中，由几家大型企业组成。 一些主要参与者正在开发新技术，以与市场上现有的畅销产品竞争。 此外，主要参与者正在引入直销力量和分销商的组合，以在全球市场上占据一席之地。 此外，一些主要参与者已建立合作伙伴关係以发展其市场地位。 目前主导市场的公司包括 Ziemer Ophthalmic Systems AG、Topcon Corporation、Carl Zeiss AG、Metall Zug Ag 和 Alcon Inc。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动因素
    • 由于糖尿病增加，全球眼科疾病发病率增加
    • 政府加大了对视力障碍控制的支持力度以及眼科设备的快速发展
  • 市场製约因素
    • 眼科设备和治疗费用飙升
    • 新兴国家/地区的眼科医生缺乏认识和技能
  • 波特的五力分析
    • 供应商的议价能力
    • 买方/消费者议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模 - 百万美元）

  • 按产品分类
    • 角膜地形图师
    • 眼底照相机
    • 检眼镜
    • 华侨城扫描仪
    • 检影镜
    • 折光仪
    • 其他
  • 通过申请
    • 视网膜评估
    • 青光眼测试
    • 手术评估
    • 折射检查
    • 其他
  • 最终用户
    • 医院
    • 专科诊所
    • 其他
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Marco Ophthalmic Inc.
    • Topcon Corporation
    • NIDEK CO., LTD
    • Carl Zeiss Meditec AG
    • Alcon Inc.
    • Lumenis Ltd
    • Metall Zug Group
    • Lumibird Group
    • EssilorLuxottica
    • Ziemer Ophthalmic Systems AG
    • Canon

第7章 市场机会今后动向

简介目录
Product Code: 67811

The ophthalmic diagnostics market studied was anticipated to grow with a CAGR of nearly 5.8% during the forecast period.

COVID-19 profoundly impacted the ophthalmic diagnostic market during the initial phases since the clinics, and primary care centres were closed due to the lockdown. As a result, the number of patients visiting for ophthalmic consultation was reduced abruptly. However, when the restrictions were relaxed, the sector recovered strongly. Over the last two years, an increase in ophthalmic diagnostics device sales, new product launches, and increased demand for ophthalmic evaluations and diagnostics are driving the market recovery.

The primary factors driving the market's growth are the various ophthalmic disorders' global prevalence, such as glaucoma, eyestrain, cataract, colourblindness, diabetic retinopathy, etc. All these prevalences necessitate early-stage diagnosis for efficient treatment. Also, a steep rise in the geriatric population results in the global burden of avoidable blindness and the growth of healthcare awareness. It leads to regular health check-ups and fuels the market. For instance, as per the 2021 update from BrightFocus Foundation, more than 3 million Americans are living with glaucoma. Out of these numbers, 2.7 million of whom-aged 40 and older are affected by its most common form, open-angle glaucoma. According to the 2022 NEI update, the estimated number of people who have had cataracts is likely to get doubled from 24.4 million to 50 million between 2010 and 2050. Hence, the rising burden of eye-related disorders and increased screening and diagnosis of the same is projecting a significant impact on the market growth. Furthermore, according to the article Frontiers published in April 2022, periodic screening (annual or biannual screening in the first five years) had exceeded nonperiodic screening in detecting diabetic retinopathy (DR) in the middle-to-advanced age group.

As per the above facts, the ophthalmic diagnostics market will likely witness growth over the forecast. However, the high cost of ophthalmic diagnostic devices and the lack of skilled professionals hinder the market growth.

Ophthalmology Diagnostics Market Trends

The Surgical Evaluation Segment is Expected to Hold a Significant Market Share in the Ophthalmic Diagnostics Market

The surgical evaluation segment is expected to witness a significant share over the forecast period owing to the higher prevalence of cataracts and diabetic retinopathy. It will lead to cataract surgeries resulting in higher demand for surgical evaluation globally. For instance, CDC reported that 17.2% of Americans over 40 years of age have a cataract in at least one eye (about 20.5 million people). By 2028, it is expected that over 30 million people will be likely to have cataracts.

Product launches, mergers, acquisitions, and research related to the ophthalmology surgical field will fuel the market growth. For instance, in July 2021, Canon launched Xephilio OCT-S1, a wide-field swept-source Optical Coherence Tomography (OCT) capable of capturing high-resolution images of up to 23 x 20 mm in a single scan. The product was unveiled to the eyecare medical practitioners at the APACRS-SNEC joint event. Canon's deep-scanning swept-source technology enables it to operate at an extensive-angle of around 80 degrees. Furthermore, in March 2022, New World Medical, a global medical device company focused on glaucoma interventions, updated its launch plans for the STREAMLINETM Surgical System. STREAMLINE, a single-use device featuring the intuitive ClickPulse Technology is a first-line implant-free system designed to create precise goniotomies in the trabecular meshwork. It also delivers small amounts of Ophthalmic Viscosurgical Device (OVD) into the canal of Schlemm in one unified step. Additionally, in July 2021, Johnson & Johnson (J&J) Vision globally launched its phacoemulsification (phaco) system, developed to provide surgeons with improved efficiency and comfort during cataract surgery. Phacoemulsification, the most frequent cataract surgical approach, allows doctors to emulsify and remove the eye's internal lens when it becomes cloudy due to cataracts.

Hence, considering the above factors, the surgical evaluation segment will likely witness growth over the forecast period.

North America is Expected to Witness a Growth in the Ophthalmology Diagnostics Market Over the Forecast Period

North America is expected to witness healthy growth in the overall ophthalmic diagnostics market throughout the forecast period due to a steep rise in the prevalence of ophthalmic disorders, such as cataracts and diabetic retinopathy, along with the massive growth of the geriatric population in the US. For instance, in 2021, the COS-SCO, during Glaucoma Awareness Month, stated that glaucoma affects more than 800,000 Canadians annually. During the awareness month, factors such as Canada's aging population contributed to a rise in disease burden. Glaucoma has the potential to become an epidemic in Canada in the coming years, which is expected to drive market growth.

Furthermore, increased government initiatives in the field of eyecare boost market growth. For instance, World Glaucoma Week is celebrated every year on March 6 to 12 to raise awareness regarding glaucoma. In 2022, the initiative's objective was "the world is bright; save your sight." Its goal was to alert people to have regular check-ups and an early diagnosis of glaucoma. Moreover, the market players adopted various strategies, such as product launches, developments, acquisitions, collaborations, mergers, and expansions, to increase market share. For instance, in January 2021, Alcon commercially launched a non-diffractive extended depth of focus intraocular lens (IOL), AcrySof, in the United States. Furthermore, in March 2022, Epipole, a provider of handheld fundus cameras, launched its new epiCam fundus camera at the Vision Expo East 2022 in New York City. The epiCam is a high-powered, ultra-portable, wireless fundus camera that captures live high-resolution video footage of the living retina and accompanying still images using epipole's new video direct ophthalmoscopy (VDO) platform.

Considering the above facts, North America is expected to witness growth over the forecast period.

Ophthalmology Diagnostics Market Competitor Analysis

The ophthalmic diagnostics market is moderately competitive and consists of several major players. Few key players are developing novel technologies to compete with the existing blockbuster products trending in the market. Furthermore, critical players in the firm are implementing a combination of direct sales force and distributors to gain a global market position. Again, a few key players are entering into partnerships to develop their market position. Some companies currently dominating the market are Ziemer Ophthalmic Systems AG, Topcon Corporation, Carl Zeiss AG, Metall Zug Ag, and Alcon Inc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increased Global Incidence of Ophthalmic Disorders Coupled with Rise in Diabetes
    • 4.2.2 Rise in Government Support to Control Visual Impairment and Rapid Advancements in the Ophthalmic Devices
  • 4.3 Market Restraints
    • 4.3.1 Higher Cost of the Ophthalmic Devices and Treatment
    • 4.3.2 Lack of Awareness and Skilled Ophthalmologists in Emerging Nations
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Product
    • 5.1.1 Corneal Topographers
    • 5.1.2 Fundus Cameras
    • 5.1.3 Ophthalmoscopes
    • 5.1.4 OCT Scanners
    • 5.1.5 Retinoscopes
    • 5.1.6 Refractors
    • 5.1.7 Others
  • 5.2 By Application
    • 5.2.1 Retinal Evaluation
    • 5.2.2 Glaucoma Detection
    • 5.2.3 Surgical Evaluation
    • 5.2.4 Refraction Assessment
    • 5.2.5 Others
  • 5.3 By End-user
    • 5.3.1 Hospitals
    • 5.3.2 Speciality Clinics
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United states
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Marco Ophthalmic Inc.
    • 6.1.2 Topcon Corporation
    • 6.1.3 NIDEK CO., LTD
    • 6.1.4 Carl Zeiss Meditec AG
    • 6.1.5 Alcon Inc.
    • 6.1.6 Lumenis Ltd
    • 6.1.7 Metall Zug Group
    • 6.1.8 Lumibird Group
    • 6.1.9 EssilorLuxottica
    • 6.1.10 Ziemer Ophthalmic Systems AG
    • 6.1.11 Canon

7 MARKET OPPORTUNITIES AND FUTURE TRENDS